Figure 1.
Comparison of progression-free survival (PFS) according to lymphoma subtype: anaplastic large cell lymphoma (ALCL) versus peripheral T-cell lymphoma, unspecified (PTCL/U) versus angioimmunoblastic (AILT) and anaplastic lymphoma kinase (ALK) expression.
Adapted with permission from
ten Berge RL, de Bruin PC, Oudejans JJ, et al. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified. Histopathology. 2003;43:462–469.
Blackwell Publishing.
